Prevention of antibody-mediated kidney transplant rejection (Q38010231)

26 August 2017

Prevention of antibody-mediated kidney transplant rejection (English)

1 reference

26 August 2017

2

Gerhard Opelz

1 reference

26 August 2017

Christian Morath

1

1 reference

PubMed ID

22587522

26 August 2017

Martin Zeier

series ordinal

3

1 reference

PubMed ID

22587522

26 August 2017

Caner Süsal

series ordinal

4

1 reference

26 August 2017

1 June 2012

1 reference

26 August 2017

Transplant International

1 reference

26 August 2017

25

1 reference

26 August 2017

6

1 reference

26 August 2017

633-645

1 reference

Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

"Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Peri-operative immunoadsorption in sensitized renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Kinetic Aspects of the Removal of IgG and Inhibitors in Hemophiliacs Using Protein A Immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Dampening Ab responses using proteasome inhibitors following in vivo B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Transplant accommodation--are the lessons learned from xenotransplantation pertinent for clinical allotransplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

The altruistic unbalanced paired kidney exchange: proof of concept and survey of potential donor and recipient attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Mechanisms of alloantibody production in sensitized renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Rejection of the kidney allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Humoral theory of transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

An integrative approach for the transplantation of high-risk sensitized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Current approaches to the management of highly sensitized kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Positive cross-match living donor kidney transplantation: longer-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01490.X

10.1111/J.1432-2277.2012.01490.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22587522